Trials / Unknown
UnknownNCT04409275
LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION
STUDY OF THE APPEARANCE OF LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, observational, multicenter study that will evaluate the changes in lung function that patients admitted with SARS-CoV-2 pneumonia will present according to the level of severity at 4, 12, 26 and 52 weeks after hospital discharge.
Detailed description
The project consists of a prospective, observational, multicenter study that will evaluate changes in lung function (forced spirometry, measurement of static lung volumes using plethysmography and pulmonary carbon monoxide diffusion test) that patients admitted with pneumonia will present. caused by SARS-CoV-2 according to the level of severity at 4, 12, 26 and 52 weeks after discharge from hospital. Restrictive pulmonary abnormalities will be confirmed by imaging tests (high resolution chest CT).
Conditions
Timeline
- Start date
- 2020-05-21
- Primary completion
- 2020-12-31
- Completion
- 2021-07-31
- First posted
- 2020-06-01
- Last updated
- 2020-06-11
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04409275. Inclusion in this directory is not an endorsement.